Evidence for macrophage-mediated protection against lethal Candida albicans infection
暂无分享,去创建一个
[1] P. Puccetti,et al. Immunoadjuvant activity of amphotericin B as displayed in mice infected with Candida albicans , 1985, Antimicrobial Agents and Chemotherapy.
[2] E. Cenci,et al. A comparison of experimental pathogenicity of Candida species in cyclophosphamide-immunodepressed mice. , 1984, Sabouraudia.
[3] P. Puccetti,et al. Phagocytic killing of Candida albicans by different murine effector cells. , 1983, Sabouraudia.
[4] P. Puccetti,et al. Natural cell-mediated cytotoxicity against Candida albicans induced by cyclophosphamide: nature of the in vitro cytotoxic effector , 1983, Infection and immunity.
[5] P. Puccetti,et al. Correlation between in vivo and in vitro studies of modulation of resistance to experimental Candida albicans infection by cyclophosphamide in mice , 1983, Infection and immunity.
[6] G. Carruba,et al. Induction of germ tube formation by N-acetyl-D-glucosamine in Candida albicans: uptake of inducer and germinative response , 1982, Journal of bacteriology.
[7] P. Puccetti,et al. A radiolabel release microassay for phagocytic killing of Candida albicans. , 1982, Journal of immunological methods.
[8] E. Bonmassar,et al. Cellular mechanisms underlying the adjuvant activity of Candida albicans in a mouse lymphoma model , 1982, International journal of cancer.
[9] H. Sandovsky-Losica,et al. Experimental vaccination with Candida albicans ribosomes in cyclophosphamide-treated animals. , 1981, Sabouraudia.
[10] P. Lagrange,et al. Absence of Correlation Between Delayed-Type Hypersensitivity and Protection in Experimental Systemic Candidiasis in Immunized Mice , 1981, Infection and immunity.
[11] M. Kasai,et al. A glycolipid on the surface of mouse natural killer cells , 1980, European journal of immunology.
[12] S. Moser,et al. Effects of cyclophosphamide on murine candidiasis , 1980, Infection and immunity.
[13] J. T. McQuitty,et al. Experimental Murine Candidiasis: Pathological and Immune Responses in T-Lymphocyte-Depleted Mice , 1978, Infection and immunity.
[14] B. Andersen,et al. Efficacy of granulocyte transfusions in the control of systemic candidiasis in the leukopenic host. , 1978, Blood.
[15] S. Landolfo,et al. Macrophage-lymphocyte interaction in migration inhibition factor (MIF) production against soluble or cellular tumor-associated antigens. I. Characteristics and genetic control of two different mechanisms of stimulating MIF production. , 1978, Journal of immunology.
[16] S. Moser,et al. Experimental murine candidiasis: cell-mediated immunity after cutaneous challenge. , 1978, Infection and immunity.
[17] N. N. Pearsall,et al. Immunologic responses to Candida albicans. III. Effects of passive transfer of lymphoid cells or serum on murine candidiasis. , 1978, Journal of immunology.
[18] J. T. McQuitty,et al. Experimental murine candidiasis: pathological and immune responses to cutaneous inoculation with Candida albicans , 1978, Infection and immunity.
[19] R. van Furth,et al. Kinetics of Phagocytosis and Intracellular Killing of Candida albicans by Human Granulocytes and Monocytes , 1977, Infection and immunity.
[20] E. Balish,et al. The role of thymus-dependent cell-mediated immunity in resistance to experimental disseminated candidiasis. , 1976, Journal of the Reticuloendothelial Society.
[21] E. Cutler. Acute systemic candidiasis in normal and congenitally thymic-deficient (nude) mice. , 1976, Journal of the Reticuloendothelial Society.
[22] C. G. Saltarelli,et al. Lethality of Candida strains as influenced by the host. , 1975, Canadian journal of microbiology.
[23] Elizabeth Simpson,et al. A rapid method for the isolation of functional thymus‐derived murine lymphocytes , 1973, European journal of immunology.
[24] J. Bennett,et al. Chronic mucocutaneous candidiasis: model-building in cellular immunity. , 1971, Annals of internal medicine.
[25] A. Bryceson. Lymphocyte abnormality in chronic mucocutaneous candidiasis. , 1970, Lancet.
[26] C. Kirkpatrick,et al. Chronic mucocutaneous moniliasis with impaired delayed hypersensitivity. , 1970, Clinical and experimental immunology.
[27] P. Quie,et al. Chronic mucocutaneous candidiasis, deficiency of delayed hypersensitivity, and selective local antibody defect. , 1967, Lancet.
[28] H. Hasenclever,et al. ACQUIRED IMMUNITY TO CANDIDIASIS IN MICE , 1963, Journal of bacteriology.
[29] L. Friedman,et al. PATHOGENICITY OF CANDIDA , 1961, Journal of bacteriology.
[30] P. Lagrange,et al. Systemic candidiasis in mice. II.--Main role of polymorphonuclear leukocytes in resistance to infection. , 1980, Annales d'immunologie.
[31] P. Leijh,et al. Kinetics ofPhagocytosis andIntracellular Killing ofCandida albicans byHumanGranulocytes andMonocytes , 1977 .
[32] K. Hirschhorn,et al. Variable cell-mediated immune defects in a family with `Candida endocrinopathy syndrome' , 1975 .